GLOO Q4 2025 Earnings Loss Per Share of 078 Amidst Operational Challenges CLDI Q4 2025 Earnings Smallerthanexpected loss highlights progress in clinicalstage biotherapeutics CRVS Q1 2026 Earnings EPS Slightly Misses Estimates Amid Continued Clinical Development VIK Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction GDS Q1 2026 Earnings Massive EPS Beat Defies Expectations Despite Stock Dip Hilltop Holdings Inc Q1 2026 Earnings EPS Beat Surprises Analysts by 30